Globalization Bill Creates Fees For Generic Pre-approval Inspections
Executive Summary
A system for assessing fees for generic drug applicants to pay for pre-approval inspections is included in the 1FDA Globalization Act introduced in the House Jan. 28
You may also be interested in...
Rx Manufacturing Safety Bill Resurfaces Without Inspection Fees
FDA's foreign and domestic oversight powers would increase under the legislation, which has been stripped down in an apparent effort to speed passage.
FDA's Poor On-Time User Fee Performance Weighs On Renewal Debate
FDA's poor on-time performance in reviewing new drug applications will be an issue as the agency and industry negotiate the outputs expected from the next Prescription Drug User Fee Act reauthorization
FDA's Poor On-Time User Fee Performance Weighs On Renewal Debate
FDA's poor on-time performance in reviewing new drug applications will be an issue as the agency and industry negotiate the outputs expected from the next Prescription Drug User Fee Act reauthorization